MedTrace Logo

CLAARITY is a Prospective, Observational, Single-arm, Multi-center, Post-market US Study Designed to Evaluate the Safety and Performance of the ECLIPTIS Left Atrial Appendage Exclusion System for Exclusion of the Left Atrial Appendage (LAA) During Concomitant Open-heart Cardiac Surgery.

NCT07742839 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 168

Last updated 2026-08-03

No results posted yet for this study

Summary

CLAARITY is a prospective, observational, single-arm, multi-center, post-market US study designed to evaluate the safety and performance of the ECLIPTIS clip in a minimum of 168 participants.

Conditions

  • Atrial Appendage

Interventions

DEVICE

Edwards ECLIPTIS Left Atrial Appendage Exclusion System

Surgical placement of the Edwards ECLIPTIS Left Atrial Appendage Exclusion System

Sponsors & Collaborators

  • Edwards Lifesciences

    lead INDUSTRY

Principal Investigators

  • Chris Malaisrie, MD · Northwestern University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-30
Primary Completion
2027-07-10
Completion
2030-08-29
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07742839 on ClinicalTrials.gov